Two drugs used in combination prove to be effective against most aggressive asbestos cancer in mice

(Centro Nacional de Investigaciones Oncol ó gicas (CNIO)) Currently, there are few effective treatments for malignant mesothelioma, although it has been decades since it was found that the major risk factor is exposure to asbestos. The drugs identified by CNIO researchers are being tested on other types of cancer, which can speed up clinical trials for mesothelioma. The authors identified molecular markers that could be used to determine which patients could benefit most from this new therapy, provided that it is approved.
Source: EurekAlert! - Cancer - Category: Cancer & Oncology Source Type: news